Understanding loneliness in young people experiencing their first episode of psychosis
Pathways to Loneliness in First-Episode Psychosis: Testing the Sociodevelopmental Model
This study is looking at how feeling lonely affects young people aged 14-30 who are going through their first episode of psychosis, and it hopes to find ways to help them feel better and recover by understanding their daily experiences with loneliness and stigma.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University (Charles River Campus) NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11161950 on NIH RePORTER |
What this research studies
This research investigates how feelings of loneliness affect young individuals aged 14-30 who are experiencing their first episode of psychosis. It aims to understand the relationship between loneliness, stigma, and the severity of psychotic symptoms through a combination of quantitative and qualitative methods. By using advanced data collection techniques, the study will analyze daily experiences of loneliness and stigma, providing insights into how these factors influence recovery. The goal is to identify ways to improve mental health outcomes for these individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are young individuals aged 14-30 who are experiencing their first episode of psychosis.
Not a fit: Patients outside the age range of 14-30 or those who have not experienced a first episode of psychosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better support strategies for young people with psychosis, ultimately improving their mental health and recovery outcomes.
How similar studies have performed: Previous research has shown that addressing loneliness and stigma can significantly improve mental health outcomes in similar populations, suggesting a promising avenue for this study.
Where this research is happening
Boston, United States
- Boston University (Charles River Campus) — Boston, United States (Active)
Researchers
- Principal investigator: Grunfeld, Gil — Boston University (Charles River Campus)
- Study coordinator: Grunfeld, Gil
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.